Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.92 $17.05 Thursday, 9th May 2024 SAGE stock ended at $12.34. This is 0.404% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.87% from a day low at $12.20 to a day high of $12.55.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Feb 11, 2016 $28.72 $30.95 $28.44 $30.66 408 300
Feb 10, 2016 $31.00 $31.60 $29.06 $29.51 315 200
Feb 09, 2016 $28.25 $31.33 $27.95 $30.04 534 100
Feb 08, 2016 $31.01 $34.38 $27.72 $28.63 656 400
Feb 05, 2016 $34.91 $36.15 $30.98 $31.49 1 017 800
Feb 04, 2016 $33.94 $36.67 $33.52 $35.13 1 001 800
Feb 03, 2016 $33.37 $34.74 $32.14 $34.43 508 200
Feb 02, 2016 $34.01 $34.01 $32.13 $33.13 272 900
Feb 01, 2016 $33.34 $36.56 $32.63 $34.39 492 600
Jan 29, 2016 $34.02 $34.60 $32.58 $33.58 555 300
Jan 28, 2016 $35.72 $35.95 $31.50 $33.55 765 100
Jan 27, 2016 $37.50 $37.86 $34.88 $35.03 371 200
Jan 26, 2016 $39.15 $39.52 $35.93 $37.35 349 300
Jan 25, 2016 $39.60 $41.36 $38.55 $38.87 452 100
Jan 22, 2016 $39.95 $42.12 $38.61 $39.85 365 600
Jan 21, 2016 $38.49 $40.31 $37.72 $38.88 689 000
Jan 20, 2016 $37.09 $38.84 $34.59 $38.35 521 500
Jan 19, 2016 $39.59 $40.34 $37.49 $38.09 414 100
Jan 15, 2016 $39.49 $40.24 $37.16 $38.92 734 800
Jan 14, 2016 $40.30 $41.80 $38.14 $41.22 632 900
Jan 13, 2016 $43.34 $44.41 $38.75 $39.51 501 800
Jan 12, 2016 $43.07 $44.96 $40.86 $42.81 387 400
Jan 11, 2016 $45.05 $45.94 $40.73 $42.42 511 000
Jan 08, 2016 $46.49 $47.50 $44.06 $44.35 669 800
Jan 07, 2016 $44.68 $47.50 $44.53 $46.39 2 759 800
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT